SCHEMBL15744698

SCHEMBL15744698

CC(C)(C)OC(=O)c1ccc(CN2C(=O)c3cccc4c(Cl)ccc(c34)C2=O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
ALDH1A1 P00352 4/20 0.57
LMNA P02545 2/20 0.57
HDAC1 Q13547 3/20 0.53
HDAC3 O15379 2/20 0.53
HDAC2 Q92769 2/20 0.53
HDAC6 Q9UBN7 2/20 0.53
HDAC10 Q969S8 1/20 0.53
KMT2A Q03164 5/20 0.50
MEN1 O00255 4/20 0.50
POLB P06746 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
MAPT P10636 3/20 0.48
HTT P42858 2/20 0.48
RGS12 O14924 1/20 0.48
USP2 O75604 1/20 0.48
RECQL P46063 1/20 0.48
CYP1A2 P05177 1/20 0.48
ERCC1 P07992 1/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10027652 0.86 LMNA (0.58) KDM4EALDH1A1LMNAHDAC1HDAC3
SCHEMBL15745146 0.85 HDAC1 (0.50) KDM4EALDH1A1LMNAHDAC1HDAC3
SCHEMBL6318770 0.84 HDAC1 (0.58) ALDH1A1HDAC1KMT2AMEN1HPGD
SCHEMBL14635730 0.76 KDM4E (0.63) KDM4EALDH1A1LMNAKMT2AMEN1
SCHEMBL24203553 0.76 HDAC1 (0.49) HDAC1HDAC6KMT2AMEN1POLB
SCHEMBL28545988 0.76 CYP1B1 (0.66) ALDH1A1LMNAHDAC1HDAC3HDAC2
SCHEMBL18537445 0.75 HDAC1 (0.60) KDM4EALDH1A1LMNAHDAC1HDAC3
SCHEMBL23563379 0.74 KMT2A (0.64) KDM4ELMNAHDAC1HDAC3HDAC2
SCHEMBL6347785 0.74 ALDH1A1 (1.00) KDM4EALDH1A1LMNAKMT2AMEN1
SCHEMBL30153490 0.74 ALDH1A1 (1.00) KDM4EALDH1A1LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2926121-B1 MULTI-LAYER DEVICE FOR SELECTIVELY DETERMINING MAGNESIUM ION OPTI MEDICAL SYSTEMS INC (US) 2017-02-22 EP disclosed
US-9360474-B2 Multi-layer device for selectively determining magnesium ion OPTI MEDICAL SYSTEMS, INC. (US) 2016-06-07 US disclosed
US-9360474-B2 Multi-layer device for selectively determining magnesium ion OPTI MEDICAL SYSTEMS, INC. (US) 2016-06-07 US disclosed
US-20140147876-A1 MULTI-LAYER DEVICE FOR SELECTIVELY DETERMINING MAGNESIUM ION IDEXX LABORATORIES, INC. (US) 2014-05-29 US disclosed
US-20140147876-A1 MULTI-LAYER DEVICE FOR SELECTIVELY DETERMINING MAGNESIUM ION IDEXX LABORATORIES, INC. (US) 2014-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140147876-A1 MULTI-LAYER DEVICE FOR SELECTIVELY DETERMINING MAGNESIUM ION ORAI1, CACYBP, CASR KDM4E 2862/4885ALDH1A1 4806/4885LMNA 1767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.